Fosamprenavir

Role

Indications

Reactions

Primary

Hiv Infection	80.4%
Antiretroviral Therapy	3.3%
Systemic Antiviral Treatment	2.9%
Acquired Immunodeficiency Syndrome	1.9%
Drug Use For Unknown Indication	1.9%
Hiv Test Positive	1.9%
Eczema	1.4%
Hepatitis C	1.0%
Investigation	1.0%
Product Used For Unknown Indication	1.0%
Prophylaxis	1.0%
Alcohol Abuse	0.5%
Candidiasis	0.5%
Epilepsy	0.5%
Hypertension	0.5%
Infection	0.5%

Rash Maculo-papular	12.5%
Renal Failure Acute	12.5%
Blood Triglycerides Increased	8.3%
Alanine Aminotransferase Increased	6.3%
Pyrexia	6.3%
Stevens-johnson Syndrome	6.3%
Anaphylactic Reaction	4.2%
Hepatitis Acute	4.2%
Mitral Valve Incompetence	4.2%
Neutropenia	4.2%
Pruritus	4.2%
Rash	4.2%
Sepsis	4.2%
Small Intestinal Obstruction	4.2%
Thinking Abnormal	4.2%
Angina Unstable	2.1%
Cellulitis	2.1%
Hyperlipidaemia	2.1%
Lymphoedema	2.1%
Nephrolithiasis	2.1%

Secondary

Hiv Infection	56.8%
Drug Use For Unknown Indication	18.6%
Drug Exposure During Pregnancy	3.2%
Hiv Test Positive	2.9%
Pneumocystis Jiroveci Infection	2.4%
Acquired Immunodeficiency Syndrome	2.1%
Human Immunodeficiency Virus Transmission	1.8%
Prophylaxis	1.8%
Tuberculosis	1.4%
Antifungal Prophylaxis	1.2%
Hepatitis C	1.1%
Antiretroviral Therapy	0.9%
Oral Candidiasis	0.9%
Depression	0.8%
Toxoplasmosis	0.8%
Disseminated Tuberculosis	0.7%
Product Used For Unknown Indication	0.7%
Prophylaxis Against Hiv Infection	0.7%
Antiviral Prophylaxis	0.6%
Candidiasis	0.6%

Vomiting	13.5%
Rash	9.4%
Pneumocystis Jiroveci Pneumonia	6.3%
Dyspnoea	5.2%
Lymphoma	5.2%
Portal Hypertension	5.2%
Premature Baby	5.2%
Renal Failure Acute	5.2%
Abortion Spontaneous	4.2%
Pulmonary Hypertension	4.2%
Septic Shock	4.2%
Skin Exfoliation	4.2%
Transient Ischaemic Attack	4.2%
Vulvitis	4.2%
White Blood Cell Count Decreased	4.2%
Lymphoedema	3.1%
Neutropenia	3.1%
Oedema Peripheral	3.1%
Productive Cough	3.1%
Renal Pain	3.1%

Concomitant

Hiv Infection	57.6%
Drug Use For Unknown Indication	19.7%
Product Used For Unknown Indication	5.0%
Acquired Immunodeficiency Syndrome	2.7%
Hypertension	2.1%
Prophylaxis	1.5%
Cytomegalovirus Infection	1.3%
Hepatitis C	1.3%
Antiretroviral Therapy	1.0%
Reflux Oesophagitis	1.0%
Systemic Antiviral Treatment	1.0%
Tuberculosis	0.9%
Antifungal Prophylaxis	0.7%
Candidiasis	0.7%
Neuropathy Peripheral	0.7%
Chronic Obstructive Pulmonary Disease	0.6%
Haemophilia	0.6%
Opportunistic Infection Prophylaxis	0.6%
Sepsis	0.6%
Convulsion	0.5%

Vomiting	10.8%
Squamous Cell Carcinoma	9.7%
Weight Decreased	6.5%
Gastroenteritis	5.4%
Renal Failure Acute	5.4%
Stomach Mass	5.4%
Transfusion Reaction	5.4%
Vaginal Haemorrhage	5.4%
Viral Load Increased	5.4%
Cardiac Failure	4.3%
Pyrexia	4.3%
Staphylococcal Sepsis	4.3%
Vertigo	4.3%
White Blood Cell Count Decreased	4.3%
Atrioventricular Block Complete	3.2%
Drug Resistance	3.2%
Insomnia	3.2%
Rash	3.2%
Torsade De Pointes	3.2%
Visual Disturbance	3.2%

Interacting

Hiv Infection	45.0%
Neuropathy Peripheral	12.2%
Hypertension	8.4%
Human Immunodeficiency Virus Transmission	7.6%
Drug Use For Unknown Indication	6.1%
Alcohol Abuse	5.3%
Antiretroviral Therapy	3.1%
Insomnia	3.1%
Basedow's Disease	2.3%
Thyroid Cyst	2.3%
Alcoholism	1.5%
Product Used For Unknown Indication	1.5%
Immunosuppressant Drug Therapy	0.8%
Sleep Disorder	0.8%